[APLS] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
21-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 13.22%
YoY- -12.21%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 99,182 94,969 44,846 22,663 22,056 16,322 14,381 261.89%
PBT -140,004 -121,843 -177,496 -167,462 -190,823 -155,491 -137,727 1.09%
Tax 233 194 282 -1,471 446 486 1,208 -66.58%
NP -140,237 -122,037 -177,778 -165,991 -191,269 -155,977 -138,935 0.62%
Tax Rate - - - - - - - -
Total Cost 239,419 217,006 222,624 188,654 213,325 172,299 153,316 34.56%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -141.39 -128.50 -396.42 -732.43 -867.20 -955.62 -966.10 -72.19%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -1.17 -1.02 -1.56 -1.50 -1.75 -1.46 -1.42 -12.10%
EPS Diluted -1.17 -1.02 -1.56 -1.50 -1.75 -1.46 -1.42 -12.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.